Molecularhealth Has Its Finger On The Pulse – Personalized Medicine As The Main Theme Of The 2014 Hauptstadtkongress Conference

HEIDELBERG, Germany & THE WOODLANDS, Texas--(BUSINESS WIRE)--MolecularHealth and innovation in the area of personalized medicine for cancer patients were high on the agenda at this year's Hauptstadtkongress conference in Berlin. Delivering the opening speech at the conference, Professor Dr. Dr. h. c. Otmar D. Wiestler, Director of the German Cancer Research Center (DKFZ), explained how cancer is a genetic disease and how this realization enables new methods in diagnosis and treatment. Today, thanks to the comprehensive characterization of a patient's personal genome, a substantial number of efficient therapeutic options is available. Wiestler started by providing visitors to the conference with an introduction to the principles of personalized medicine. Based on this foundation and the latest knowledge from genome research, MolecularHealth developed its medical device, TreatmentMAP™.

Help employers find you! Check out all the jobs and post your resume.